Clarifying the grey zone: a proposal
CFG proposes a new EU governance category for wellness neurotechnology devices and sets out what it would take to make it work.
Introducing “Neurotech between wellness and medicine”
Consumer neurotechnology devices are multiplying fast — and slipping through the gap between medical regulation and the consumer market. CFG examines the tensions driving this grey zone, and what regulators can do about it.
Mapping neurotech governance
This interactive map provides an overview of the fragmented regulatory landscape governing neurotechnology in Europe and beyond.
Towards inclusive EU governance of neurotechnologies
Our report explores ethical and regulatory challenges in Neurotechnology, highlights key grey areas, and makes recommendations for EU governance of Neurotech devices.
Navigating the neurotechnology frontier
Neurotechnologies, the next frontier in medicine and human enhancement, pose societal risks. CFG’s program anticipates these challenges and explores EU regulations.